OneMedNet Shares Surge 28% After 11.5M Share Registration & Data Expansion

Introduction

OneMedNet Corporation (Nasdaq: ONMD) is a public company specializing in Real-World Data (RWD) solutions for healthcare and adjacent industries. Founded in 2006 and headquartered in Eden Prairie, Minnesota, OneMedNet provides de-identified, regulatory-grade clinical and imaging data through its proprietary iRWD™ platform. The company’s services support pharmaceutical manufacturers, medical device developers, and artificial intelligence (AI) developers by offering longitudinal patient records, administrative claims data, and masked production data for testing and simulation.

Corporate Structure

OneMedNet operates with a workforce of 11–50 employees and maintains a network of over 1,750 healthcare system and provider sites. Key executives include Aaron Green (President and CEO), Dr. Jeffrey Yu (Vice President and Chief Medical Officer), Bob Golden (Chief Financial Officer), and Steven Chartier (VP Engineering and Chief of Data). The Board of Directors is supported by four standing committees—Audit; Compensation; Nominating & Corporate Governance; and Commercial—ensuring oversight of financial reporting, executive compensation, governance standards, and business development.

Real-World Data by Luke Chesser

Recent Developments

• On August 13, 2025, OneMedNet filed a Form 424B3 prospectus supplement registering up to 11.5 million new shares and approximately 28.2 million shares for resale, which reflects ongoing capital-raising efforts following its merger with Data Knights Acquisition Corp.
• The same day, the company incorporated its Quarterly Report on Form 10-Q for the period ended June 30, 2025, into the prospectus supplement, providing updated financial performance metrics and management analysis.
• In a press release dated August 4, 2025, OneMedNet reported access to 1,750 provider sites and 136 million clinical exams, indicating expanded data coverage.
• On June 25, 2025, the company announced new agreements to enhance its regulatory-grade imaging RWD capabilities.
• On May 13, 2025, OneMedNet revealed expanded platform features intended to improve data curation and user-defined cohort queries.

Financial and Strategic Analysis

As of August 14, 2025, ONMD shares closed at $0.6150, reflecting a percentage increase of 28.13% on a trading volume of 13,164,478 shares. Key financial metrics (ttm) include:

• Revenue: $532,000
• Net Loss: $9.92 million
• EPS: –$0.35
• Market Capitalization: $22.82 million
• Price/Sales Ratio: 28.15
• Enterprise Value/Revenue: 55.26
• Total Cash: $144,000
• Levered Free Cash Flow: $8.66 million

The company's price/sales and enterprise value/revenue multiples indicate its early-stage revenue base and ongoing investments in platform development and network expansion. As an emerging growth company under the JOBS Act, OneMedNet is subject to reduced reporting requirements while pursuing strategic initiatives in data acquisition, AI-driven de-identification, and subscription-based service models.

Market Position and Industry Context

OneMedNet competes in the RWD market, where the demand for longitudinal patient data is influenced by regulatory agencies and pharmaceutical research and development. Its iRWD™ platform stands out by offering:

1. Comprehensive Clinical and Imaging Data: Longitudinal records that include electronic health records, laboratory results, and radiology studies.
2. Regulatory-Grade Compliance: De-identification aligned with HIPAA standards and validated through human oversight to ensure data integrity.
3. Subscription and Curated Access: Continuous cohort updates and expert curation services that support development timelines.

Competitors in this space include various RWD aggregators and analytics providers. However, OneMedNet’s focus on imaging data and its large network of provider sites positions it to address specific needs in areas such as oncology and cardiology.

tl;dr

On August 13 and 14, 2025, OneMedNet’s share price increased over 28% amid filings registering 11.5 million new shares while Q2 financials reported $532,000 in revenue and a $9.92 million net loss. The company accessed 1,750 provider sites and 136 million clinical exams as of June 30, 2025, and has enhanced its iRWD™ imaging capabilities through new agreements. With a market capitalization of $22.8 million, OneMedNet is actively pursuing capital raises following its SPAC merger and focusing on subscription-based RWD services.